56962-11-9 Usage
Description
2-Chloro-4-hydroxybenzaldehyde is an organic compound that serves as a crucial intermediate in various chemical syntheses. It is characterized by the presence of a chlorine atom at the 2nd position and a hydroxyl group at the 4th position of the benzene ring, with an aldehyde group attached to the carbonyl end. 2-Chloro-4-hydroxybenzaldehyde is known for its versatile reactivity and is widely utilized in the production of pharmaceuticals, agrochemicals, and dyestuffs.
Uses
Used in Organic Synthesis:
2-Chloro-4-hydroxybenzaldehyde is used as an important raw material and intermediate in organic synthesis. Its unique structure allows for a range of chemical reactions, making it a valuable component in the creation of various complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Chloro-4-hydroxybenzaldehyde is used as a key intermediate for the synthesis of various drugs. Its reactivity and functional groups enable the development of new medicinal compounds with potential therapeutic applications.
Used in Agrochemical Industry:
2-Chloro-4-hydroxybenzaldehyde is also utilized in the agrochemical industry, where it serves as a starting material for the synthesis of pesticides and other agricultural chemicals. Its properties make it suitable for the development of effective and targeted pest control solutions.
Used in Dyestuff Industry:
In the dyestuff industry, 2-Chloro-4-hydroxybenzaldehyde is employed as a vital intermediate for the production of various dyes and pigments. Its chemical structure contributes to the development of a wide range of colorants with diverse applications in textiles, plastics, and other industries.
Used in Chemical Synthesis:
2-Chloro-4-hydroxybenzaldehyde may be used in chemical synthesis for the preparation of N-thioamide thiosemicarbazone derivatives. These derivatives have been synthesized and studied for their potential applications in various fields.
General Description:
The general description of 2-Chloro-4-hydroxybenzaldehyde includes its preparation as N-thioamide thiosemicarbazone derivatives. Additionally, the acid dissociation constant (pKa) values for 2-chloro-4-hydroxybenzaldehyde have been evaluated, providing insights into its chemical properties and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 56962-11-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,6 and 2 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 56962-11:
(7*5)+(6*6)+(5*9)+(4*6)+(3*2)+(2*1)+(1*1)=149
149 % 10 = 9
So 56962-11-9 is a valid CAS Registry Number.
56962-11-9Relevant articles and documents
Synthesis of the β2-Agonist Tulobuterol and Its Metabolite 4-Hydroxytulobuterol
Burdeinyi, M. L.,Glushkova, M. A.,Popkov, S. V.
, p. 390 - 394 (2020/04/27)
Abstract: Alternative methods have been developed for the synthesis of theβ2-agonist tulobuterol and its metabolite4-hydroxytulobuterol with a similar activity. The proposed procedures utilizeavailable reagents, and the key stage in the synthesis is the formation ofintermediate oxirane according to the Corey–Chaykovsky reaction, followed byopening of the oxirane ring by the action of excess tert-butylamine. In the synthesis of 4-hydroxytulobuterol, thehydroxy group was protected by benzylation, and the protecting group was removedin the final stage by hydrogenation over carbon-supported palladium.
NOVEL FXR (NR1H4 ) BINDING AND ACTIVITY MODULATING COMPOUNDS
-
Page/Page column 45; 47; 48, (2011/04/13)
The present invention relates to compounds which bind to the NR1 H4 receptor (FXR) and act as agonists of the NR1 H4 receptor (FXR). The invention further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds, and to a process for the synthesis of said compounds.
C-PHENYL GLYCITOL COMPOUND
-
Page/Page column 83-85, (2008/06/13)
Provided is a novel C-phenyl glycitol compound that may serve as a prophylactic or therapeutic agent for diabetes by inhibiting both SGLT1 activity and SGLT2 activity, thereby exhibiting a glucose absorption suppression action and a urine glucose excretion action. A C-phenyl glycitol compound represented by Formula (I) below or a pharmaceutically acceptable salt thereof or a hydrate thereof wherein R1 and R2 are the same or different and represent a hydrogen atom, a hydroxyl group, a C1-6 alkyl group, a C1-6 alkoxy group or a halogen atom, R3 is a hydrogen atom, a C1-6 alkyl group, a C1-6 alkoxy group or a halogen atom, Y is a C1-6 alkylene group, -O-(CH2)n- (n is an integer of 1 to 4) or a C2-6 alkenylene group, provided that when Z is NHC(= NH)NH2 or -NHCON(RB)RC, n is not 1, Z is -CONHRA, -NHC(=NH)NH2 or -NHCON(RB)RC, Formula (A) or Formula (B).